Kristin Stephens - 01 Apr 2022 Form 4 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Chief Development Officer
Signature
/s/ Kristin Stephens
Issuer symbol
SYRS
Transactions as of
01 Apr 2022
Net transactions value
-$15,809
Form type
4
Filing time
04 Apr 2022, 17:04:14 UTC
Previous filing
17 Feb 2022
Next filing
11 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYRS Common Stock Tax liability $15,809 -14,115 -31% $1.12 30,885 01 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares used to cover tax withholding on a Restricted Stock Unit release.